The selective metabotropic glutamate receptor 5 antagonist mavoglurant (AFQ056) reduces the incidence of reflux episodes in dogs and patients with moderate to severe gastroesophageal reflux disease.
about
The selective metabotropic glutamate receptor 5 antagonist mavoglurant (AFQ056) reduces the incidence of reflux episodes in dogs and patients with moderate to severe gastroesophageal reflux disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The selective metabotropic glu ...... stroesophageal reflux disease.
@en
type
label
The selective metabotropic glu ...... stroesophageal reflux disease.
@en
prefLabel
The selective metabotropic glu ...... stroesophageal reflux disease.
@en
P2093
P2860
P356
P1476
The selective metabotropic glu ...... stroesophageal reflux disease.
@en
P2093
H-D Allescher
M-L Rouzade-Dominguez
P Malfertheiner
S Bruley des Varannes
P2860
P356
10.1111/NMO.13058
P50
P577
2017-03-23T00:00:00Z